| Dr Lance Budge Thigpen, MD | |
|
1 Anna Marsh Lane, Brattleboro, VT 05302 | |
| (802) 258-7785 | |
| (802) 258-3723 |
| Full Name | Dr Lance Budge Thigpen |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 25 Years |
| Location | 1 Anna Marsh Lane, Brattleboro, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386739209 | NPI | - | NPPES |
| 003195401 | Other | VT | MEDICARE |
| 3086728 | Medicaid | NH | |
| 1021583 | Medicaid | VT | |
| 797863397A | Medicaid | GA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brattleboro Retreat | 7012828908 | 55 |
News Archive
IsoRay, Inc. announced today it has shipped its first GliaSite radiation therapy system. The Company initiated sales after receiving final approval this week from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced the closing of a bridge loan pursuant to a Note and Warrant Purchase Agreement. Under the terms of the loan, the Company sold promissory notes in the aggregate principal amount of $1.0 million and issued warrants to purchase an aggregate of approximately 1.1 million shares of the Company's common stock at $1.02 per share to certain accredited investors.
Oregon Health & Science University (OHSU) researchers will unveil research results that help explain why middle-aged women develop central body fat.
› Verified 7 days ago
| Entity Name | Brattleboro Retreat |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730185232 PECOS PAC ID: 7012828908 Enrollment ID: O20041123000627 |
News Archive
IsoRay, Inc. announced today it has shipped its first GliaSite radiation therapy system. The Company initiated sales after receiving final approval this week from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced the closing of a bridge loan pursuant to a Note and Warrant Purchase Agreement. Under the terms of the loan, the Company sold promissory notes in the aggregate principal amount of $1.0 million and issued warrants to purchase an aggregate of approximately 1.1 million shares of the Company's common stock at $1.02 per share to certain accredited investors.
Oregon Health & Science University (OHSU) researchers will unveil research results that help explain why middle-aged women develop central body fat.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lance Budge Thigpen, MD 1 Anna Marsh Lane, Brattleboro, VT 05302 Ph: (802) 258-7785 | Dr Lance Budge Thigpen, MD 1 Anna Marsh Lane, Brattleboro, VT 05302 Ph: (802) 258-7785 |
News Archive
IsoRay, Inc. announced today it has shipped its first GliaSite radiation therapy system. The Company initiated sales after receiving final approval this week from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system.
Teva Pharmaceutical Industries Ltd., has presented results from a post hoc analysis of two pivotal Phase III clinical trials showing that treatment with reslizumab reduced clinical asthma exacerbations (CAEs) by 75 percent versus placebo in a subgroup of patients with late onset asthma (diagnosed at 40 years of age and older) with elevated blood eosinophils, who were inadequately controlled on inhaled corticosteroids (ICS).
MDRNA, Inc., a leading RNAi-based drug discovery and development company, today announced the closing of a bridge loan pursuant to a Note and Warrant Purchase Agreement. Under the terms of the loan, the Company sold promissory notes in the aggregate principal amount of $1.0 million and issued warrants to purchase an aggregate of approximately 1.1 million shares of the Company's common stock at $1.02 per share to certain accredited investors.
Oregon Health & Science University (OHSU) researchers will unveil research results that help explain why middle-aged women develop central body fat.
› Verified 7 days ago
Dr. Saba Salam, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 830 Western Ave, Brattleboro, VT 05301 Phone: 802-246-0781 Fax: 802-246-0742 | |
Timothy Larosa, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-258-3707 Fax: 802-258-3788 | |
Dorothea L. De Gutis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 | |
Dr. Milangel Thaymee Concepcion Zayas, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro Retreat- Anna Marsh Behavioral Care Clinic, Brattleboro, VT 05302 Phone: 802-257-7785 | |
Elizabeth H Joseph, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Anna Marsh Lane, Brattleboro Retreat, Brattleboro, VT 05302 Phone: 802-258-4354 | |
Stuart A. Copans, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St., Hcrs, Brattleboro, VT 05301 Phone: 802-254-6028 |